Cargando...

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact

BACKGROUND: Administration of interleukin-2 (IL-2) has shown some effects on malignant pleural mesothelioma (MPM) tumour regression. The purpose of this study was to investigate the ability of IL-2 to modify immunological effector cells and angiogenesis in MPM patients and their prognostic value. ME...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Alì, G, Boldrini, L, Lucchi, M, Picchi, A, Dell'Omodarme, M, Prati, M C, Mussi, A, Corsi, V, Fontanini, G
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2009
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2788262/
https://ncbi.nlm.nih.gov/pubmed/19935800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605438
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!